ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RENE Reneuron Group Plc

3.05
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.05 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 530k -5.41M -0.0946 -0.32 1.74M
Reneuron Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker RENE. The last closing price for Reneuron was 3.05p. Over the last year, Reneuron shares have traded in a share price range of 2.95p to 10.25p.

Reneuron currently has 57,173,760 shares in issue. The market capitalisation of Reneuron is £1.74 million. Reneuron has a price to earnings ratio (PE ratio) of -0.32.

Reneuron Share Discussion Threads

Showing 7826 to 7847 of 8900 messages
Chat Pages: Latest  320  319  318  317  316  315  314  313  312  311  310  309  Older
DateSubjectAuthorDiscuss
24/2/2020
19:29
Better to pop down to Kwik Fit and swap out the whole thing for the new improved model :)


The horror! The horror!

supernumerary
24/2/2020
17:48
Yes, brain implants needed for presbyopia. One day.
small crow
24/2/2020
16:23
personally think these results are excellent, all things considered
martinfrench
24/2/2020
15:06
That's clever!

Unfortunately none of these solutions really address the problem of presbyopia - what's needed is a way of making the lens more flexible, not just more or less powerful. I imagine it will come (or perhaps it's here and I haven't heard of it yet?).

supernumerary
24/2/2020
14:56
Also consider "Light Adjustable Lenses" SC as they can be put into the eye and altered/adjusted when actually inside the eye by shining various frequency light at them and then locking them into shape when the optimum configuration is achieved.
algernon2
24/2/2020
14:29
PS Yes, that's one reason I've always avoided laser .... eyes do change and you cannot undue. Better option, which I might consider for one of my eyes (the more astigmatic) is an intraocular lens. You can always take it out and stuff in another.... for a price.
small crow
24/2/2020
14:27
Agreed. I think the only "downside" is that things may be as good as they get after 12 months, rather than continuing to improve. However, if your sight is going to probably don't want to wait 3 years for improvement and, also positive, this is just the first draft of a therapeutic. Things can only get better, as Mr Blair used to say.
small crow
24/2/2020
12:32
sc - I've had the same transition - started short-sighted (very!), had it fixed by laser (giving excellent all-round vision), and now long-sighted and forever fiddling with pairs of reading glasses - infuriating!

I also think the news is reassuring. The first requirement is always that things shouldn't get worse, and I think we can now safely abandon that possibility. So we're only looking at degrees of success, which is a nice position to be in.

I'm also pleased they're now showing improvement of treated eye over untreated, rather than just improvement over baseline, as that eliminates some of the baseline movement which might occur with age-related changes, or variations in general health.

supernumerary
24/2/2020
11:06
Yes, thanks super, I still think that's what might be happening. The most common cause of people wearing glasses for years and then not needing them is that most of us tend to become more 'long-sighted' as we age, so all of those who needed correction for short-sight (ie loads of us) tend to need them less as we get older. I'm typical - my eyes have shifted about +2 diopter units over the last 40 years - I used to need specs for driving but not now.

Anyway, The data looks a bit better with increasing samples but I would guess the market is still worried about a potential decline in acuity after 9 months and will want to see a longer time series. FWIW, my opinion is that the better measurement to use, as a real indicator of the improvement as perceived by the patient, is the sum of the improvement in both eyes. On that measure the improvement in what they see (ie with both) begins at around 12 units, increases to 24 units at 9 months, and declines far less between 9 and 12 months. Either way, I suspect the market is reassured (ie no catastrophe) but will need to see more before hands go in pockets.

small crow
24/2/2020
10:17
cotton - I think this is a more likely explanation:

small crow26 Oct '19 - 10:32 - 7427 of 7560 0 1 1
Nobby, thanks for that. I'm not that surprised that the untreated eye seems to improve as you have to factor in the computational stuff between the retina and the "perception" to get the final result. It could be the case that better input to the visual centres/optic tectum is causing changes that benefit the signal processing in both eyes. It's like a mild case of the groundbreaking Colin Blakemore experiment where he demonstrated that, if you raise animals from birth in an environment where they never see a horizontal line, then transfer them to a regular environment, they can't perceive horizontal lines. In this case the signal processing is not used to processing a "sharp" image but, once presented with one, gets better at doing it. It's an idea and, more importantly, good news for both eyes.

supernumerary
24/2/2020
09:43
It is a really, really bad day for the market. Not declining with it is a major achievement.
dickbush
24/2/2020
08:52
ID, Rene is fickle, news comes out and sometimes it takes it time to react. Rather have positive news than the other but just wish we could get that good one in order to get things moving. Zoo
zooman
24/2/2020
08:19
Oh well. Looks like the market doesn't think much of that update either.
investordave
24/2/2020
08:13
Wow. Very interesting. I Did not know that. Tx
cottonpickers
24/2/2020
08:10
As less strain is placed on the unaffected eye it will strengthen. Some people that wear glasses for years can end up not needing them as less strain is placed on the eyes
peteark
24/2/2020
07:30
I'm curious how the non medicated eye also shows some (smaller) progress over time. I would expect it to deteriorate over a 12m period but I'd does not. Is that placebo effect? I would not expect placebo would allow you to read more lines. Thoughts?
cottonpickers
24/2/2020
07:21
Positive news, let's see what the market make of it
ayl30
24/2/2020
07:08
The news we have all been waiting for!
bonzo
23/2/2020
07:57
Do not click that link from petershares1- same spam link as yesterday. There is no Times article..
dplewis1
22/2/2020
22:06
hxxps://youtu.be/i2xK3Ls0jFU
peteark
22/2/2020
12:07
I was thinking about a takeover bid by someone in the industry. A third of the company has been available for weeks, if not months. Even now, the very recent buyer of 16% would, I'm sure, be very happy to take a fast profit.
dickbush
19/2/2020
17:31
I have to wonder why-if RENE has such great prospects-no one seems to want to buy it on the cheap.
dickbush
Chat Pages: Latest  320  319  318  317  316  315  314  313  312  311  310  309  Older

Your Recent History

Delayed Upgrade Clock